Literature DB >> 14001284

Suppression of allergic uveitis by 6-mercaptopurine.

E WIROSTKO, S P HALBERT.   

Abstract

Experimental uveitis in rabbits was induced by single intraocular antigen injection. Treatment with 6-MP for 14 days suppressed the allergic inflammation and antibody response. A good correlation was demonstrated between the degree of uveitis and the antibody titer.

Entities:  

Keywords:  ALLERGY; MERCAPTOPURINE; UVEITIS

Mesh：

Substances：

Year:  1962        PMID： 14001284      PMCID： PMC2137557          DOI： 10.1084/jem.116.5.653

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  10 in total

1.  On the mechanism of action of 6-mercaptopurine.

Authors:  H E SKIPPER
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

2.  An immunological pregnancy test.

Authors:  L WIDE; C A GEMZELL
Journal:  Acta Endocrinol (Copenh)       Date:  1960-10

3.  Experimental ocular hypersensitivity. Histopathologic changes observed in rabbits receiving a single injection of antigen into the vitreous.

Authors:  L E ZIMMERMAN; A M SILVERSTEIN
Journal:  Am J Ophthalmol       Date:  1959-11       Impact factor: 5.258

4.  Drug-induced immunological tolerance.

Authors:  R SCHWARTZ; W DAMESHEK
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

5.  Immunological studies with I 131 labeled antigen in experimental uveitis.

Authors:  A N FERNANDO
Journal:  Arch Ophthalmol       Date:  1960-03

6.  Effects of steroids on aspects of the metabolism and functions of the lymphocyte: a hypothesis of the cellular mechanisms in antibody formation and related immune phenomena.

Authors:  A WHITE
Journal:  Ann N Y Acad Sci       Date:  1958-09-05       Impact factor: 5.691

7.  Prevention of experimental allergic encephalomyelitis with 6-mercaptopurine.

Authors:  L W HOYER; R M CONDIE; R A GOOD
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

8.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

9.  Radiosensitive and radioresistant phases in the antibody response.

Authors:  F J DIXON; D W TALMAGE; P H MAURER
Journal:  J Immunol       Date:  1952-06       Impact factor: 5.422

10.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307
  10 in total
  1 in total

1.  Long-lasting remission of Behcet's disease after chlorambucil therapy.

Authors:  M I Abdalla; N el-D Bahoat
Journal:  Br J Ophthalmol       Date:  1973-09       Impact factor: 4.638
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.